|
[1]SENGER DR, WIRTH DF, HYNES RO.Transformed mammalian cells secrete specific proteins and phosphoproteins[J].Cell, 1979, 16 (4) :885-893.
|
|
[2]OLDBERG A, FRANZEN A, HEINEGARD D.Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence[J].Proc Natl Acad Sci U S A, 1986, 83 (23) :8819-8823.
|
|
[3]MUSSO G, PASCHETTA E, GAMBINO R, et al.Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver[J].Trends Mol Med, 2013, 19 (9) :522-535.
|
|
[4]KAWASHIMA R, MOCHIDA S, MATSUI A, et al.Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication:a possible factor for macrophage migration into hepatic necrotic areas[J].Biochem Biophys Res Commun, 1999, 256 (3) :527-531.
|
|
[5]RAMAIAH SK, RITTLING S.Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer[J].Toxicol Sci, 2008, 103 (1) :4-13.
|
|
[6]GIMBA ER, TILLI TM.Human osteopontin splicing isoforms:known roles, potential clinical applications and activated signaling pathways[J].Cancer Lett, 2013, 331 (1) :11-17.
|
|
[7]YOKOSAKI Y, TANAKA K, HIGASHIKAWA F, et al.Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin[J].Matrix Biol, 2005, 24 (6) :418-427.
|
|
[8]SODEK J, GANSS B, McKEE MD.Osteopontin[J].Crit Rev Oral Biol Med, 2000, 11 (3) :279-303.
|
|
[9]CHA JH, AHN YH, LIM SW, et al.Decreased osteopontin expression in the rat kidney on a sodium deficient diet[J].Yonsei Med J, 2000, 41 (1) :128-135.
|
|
[10]ISODA K.Osteopontin Transgenic Mice Fed a High-Cholesterol Diet Develop Early Fatty-Streak Lesions[J].Circulation, 2003, 107 (5) :679-681.
|
|
[11]APTE UM, BANERJEE A, McREE R, et al.Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis[J].Toxicol Appl Pharmacol, 2005, 207 (1) :25-38.
|
|
[12]MORALES-IBANEZ O, DOMINGUEZ M, KI SH, et al.Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis[J].Hepatology, 2013, 58 (5) :1742-1756.
|
|
[13]YILMAZ Y, OZTURK O, ALAHDAB YO, et al.Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease[J].Dig Liver Dis, 2013, 45 (1) :58-62.
|
|
[14]DIAO H, LIU X, WU Z, et al.Osteopontin regulates interleukin-17 production in hepatitis[J].Cytokine, 2012, 60 (1) :129-137.
|
|
[15]FAN K, ZHANG B, YANG H, et al.A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice[J].Eur J Pharmacol, 2011, 657 (1-3) :144-151.
|
|
[16]KIEFER FW, NESCHEN S, PFAU B, et al.Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice[J].Diabetologia, 2011, 54 (8) :2132-2142.
|
|
[17]BASSYOUNI IH, BASSYOUNI RH, IBRAHIM NH, et al.Elevated serum osteopontin levels in chronic hepatitis C virus infection:association with autoimmune rheumatologic manifestations[J].J Clin Immunol, 2012, 32 (6) :1262-1269.
|
|
[18]SHAKER O, EL-SHEHABY A, FAYEZ S, et al.Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4[J].Cell Biochem Funct, 2013, 31 (7) :620-625.
|
|
[19]ZHAO L, LI T, WANG Y, et al.Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection[J].Int J Clin Pract, 2008, 62 (7) :1056-1062.
|
|
[20]HUANG W, ZHU G, HUANG M, et al.Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects[J].Clin Chim Acta, 2010, 411 (9-10) :675-678.
|
|
[21]SYN WK, AGBOOLA KM, SWIDERSKA M, et al.NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease[J].Gut, 2012, 61 (9) :1323-1329.
|
|
[22]TOKAIRIN T, NISHIKAWA Y, WATANABE H, et al.Osteopontin expression in the liver with severe perisinusoidal fibrosis:autopsy case of Down syndrome with transient myeloproliferative disorder[J].Pathol Int, 2008, 58 (1) :64-68.
|
|
[23]XIAO X, GANG Y, GU Y, et al.Osteopontin contributes to TGF-beta1 mediated hepatic stellate cell activation[J].Dig Dis Sci, 2012, 57 (11) :2883-2891.
|
|
[24]URTASUN R, LOPATEGI A, GEORGE J, et al.Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha (V) beta (3) engagement and PI3K/pAkt/NFkappaB signaling[J].Hepatology, 2012, 55 (2) :594-608.
|
|
[25]PRITCHETT J, HARVEY E, ATHWAL V, et al.Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans[J].Hepatology, 2012, 56 (3) :1108-1116.
|
|
[26]CHEN BL, ZHANG GY, YUAN WJ, et al.Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice[J].World J Gastroenterol, 2011, 17 (46) :5075-5082.
|
|
[27]NAGOSHI S.Osteopontin:Versatile modulator of liver diseases[J].Hepatol Res, 2014, 44 (1) :22-30.
|
|
[28]LIU W, XU G, MA J, et al.Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma[J].Tohoku J Exp Med, 2011, 224 (1) :29-39.
|
|
[29]ZHANG R, PAN X, HUANG Z, et al.osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines[J].PLoS One, 2011, 6 (8) :e23831.
|
|
[30]PHILLIPS RJ, HELBIG KJ, van der HOEK KH, et al.Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner[J].World J Gastroenterol, 2012, 18 (26) :3389-3399.
|
|
[31]CHEN RX, XIA YH, XUE TC, et al.Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression[J].J Exp Clin Cancer Res, 2010, 29:172.
|
|
[32]WU Y, JIANG W, WANG Y, et al.Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression[J].PLoS One, 2012, 7 (8) :e42976.
|
|
[33]XUE YH, ZHANG XF, DONG QZ, et al.Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma[J].Hepatology, 2010, 52 (6) :2012-2022.
|
|
[34]XIE H, SONG J, DU R, et al.Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma[J].Dig Liver Dis, 2007, 39 (2) :167-172.
|
|
[35]ZHOU C, ZHOU HJ, ZHANG XF, et al.Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma[J].Ann Surg Oncol, 2013, 20 (3) :929-937.
|
|
[36]EL-DIN BESSA SS, ELWAN NM, SULIMAN GA, et al.Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma[J].Arch Med Res, 2010, 41 (7) :541-547.
|
|
[37]KIM SH, CHUNG YH, YANG SH, et al.Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization[J].Korean J Hepatol, 2009, 15 (3) :320-330.
|
|
[38]SULPICE L, RAYAR M, DESILLE M, et al.Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma[J].Hepatology, 2013, 58 (6) :1992-2000.
|
|
[39]HUANG J, PAN C, HU H, et al.Osteopontin-enhanced hepatic metastasis of colorectal cancer cells[J].PLoS One, 2012, 7 (10) :e47901.
|
|
[40]SUN L, PAN J, PENG L, et al.Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis[J].Ann Surg Oncol, 2012, 19 (7) :2411-2419.
|
|
[41]DONG QZ, ZHANG XF, ZHAO Y, et al.Osteopontin promoter polymorphisms at locus-443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma[J].Hepatology, 2013, 57 (3) :1024-1034.
|
DownLoad: